Fig 1.
Study design showing period of cohort data collection and ART transition in 21 health facilities in Lesotho; January 2018–May 2022.
* Includes all cohort participants who initiated antiretroviral therapy between January 2018 and March 2020.
Table 1.
Demographic and treatment characteristics of 310 children (0–14 years of age) at ART initiation in 21 health facilities in Lesotho; January 2018-May 2022.
Fig 2.
Follow-up outcomes of 310 participants enrolled in 21 study health facilities; January 2018–May 2022.
*LTFU = Loss to follow-up; †Transferred = Participant relocated to non-study site. §Withdrew/Lost interest: participant remained in care but either withdrew from the study or were no longer interested in study follow-up. ǂTerminated = Due to resource constraints, the study was stopped before some participants completed 24 months follow-up.
Table 2.
ART switches and substitutions by age category documented at 21 health facilities in Lesotho, January 2018–May 2022.
Table 3.
Changes in LPV/r formulations by type of enrolment at 21 health facilities in Lesotho; January 2018–ay 2022.
Table 4.
Viral suppression by age and drug regimen, among 116 children with VL result after ≥6 months of consecutive drug: Results from 21 health facilities in Lesotho; January 2018-May 2022.